Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Adolescent experience of psychotropic treatment.

Floersch J, Townsend L, Longhofer J, Munson M, Winbush V, Kranke D, Faber R, Thomas J, Jenkins JH, Findling RL.

Transcult Psychiatry. 2009 Mar;46(1):157-79. doi: 10.1177/1363461509102292.

2.

Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review.

Gao K, Kemp DE, Ganocy SJ, Gajwani P, Xia G, Calabrese JR.

J Clin Psychopharmacol. 2008 Apr;28(2):203-9. doi: 10.1097/JCP.0b013e318166c4d5. Review.

3.

Course and outcome of bipolar spectrum disorder in children and adolescents: a review of the existing literature.

Birmaher B, Axelson D.

Dev Psychopathol. 2006 Fall;18(4):1023-35. Review.

PMID:
17064427
4.

Phenomenology of children and adolescents with bipolar spectrum disorders.

Axelson D, Birmaher B, Strober M, Gill MK, Valeri S, Chiappetta L, Ryan N, Leonard H, Hunt J, Iyengar S, Bridge J, Keller M.

Arch Gen Psychiatry. 2006 Oct;63(10):1139-48.

PMID:
17015816
5.

Conduct problems, depressive symptomatology and their co-occurring presentation in childhood as predictors of adjustment in early adolescence.

Ingoldsby EM, Kohl GO, McMahon RJ, Lengua L; Conduct Problems Prevention Research Group.

J Abnorm Child Psychol. 2006 Oct;34(5):603-21.

6.

What would the patient choose? Subjective comparison of atypical and typical neuroleptics.

Karow A, Schnedler D, Naber D.

Pharmacopsychiatry. 2006 Mar;39(2):47-51.

PMID:
16555164
8.

Subjective distress related to side effects and subjective well-being in first admitted adolescents with early-onset psychosis treated with atypical antipsychotics.

Schimmelmann BG, Paulus S, Schacht M, Tilgner C, Schulte-Markwort M, Lambert M.

J Child Adolesc Psychopharmacol. 2005 Apr;15(2):249-58.

PMID:
15910209
9.

Pharmacophilia and pharmacophobia: determinants of patients' attitudes towards antipsychotic medication.

Sibitz I, Katschnig H, Goessler R, Unger A, Amering M.

Pharmacopsychiatry. 2005 May;38(3):107-12.

PMID:
15902579
10.

Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype.

Geller B, Tillman R, Craney JL, Bolhofner K.

Arch Gen Psychiatry. 2004 May;61(5):459-67.

PMID:
15123490
11.

Subjective response to antipsychotics of schizophrenia patients treated in routine clinical practice: a naturalistic comparative study.

Ritsner M, Perelroyzen G, Ilan H, Gibel A.

J Clin Psychopharmacol. 2004 Jun;24(3):245-54.

PMID:
15118477
12.

Enhancement of treatment adherence among patients with bipolar disorder.

Sajatovic M, Davies M, Hrouda DR.

Psychiatr Serv. 2004 Mar;55(3):264-9. Review.

PMID:
15001726
13.

Switching to quetiapine in patients with acute mania who were intolerant to risperidone.

Pae CU, Lee KU, Kim JJ, Lee CU, Bahk WM, Lee SJ, Lee C, Paik IH.

Hum Psychopharmacol. 2004 Jan;19(1):47-51.

PMID:
14716712
14.

Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia.

Jeste SD, Patterson TL, Palmer BW, Dolder CR, Goldman S, Jeste DV.

Schizophr Res. 2003 Sep 1;63(1-2):49-58.

PMID:
12892857
15.
16.
17.

Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: a discriminant function analysis.

Donohoe G, Owens N, O'Donnell C, Burke T, Moore L, Tobin A, O'Callaghan E.

Eur Psychiatry. 2001 Aug;16(5):293-8.

PMID:
11514132
18.

The relationship between quality and outcomes in routine depression care.

Fortney J, Rost K, Zhang M, Pyne J.

Psychiatr Serv. 2001 Jan;52(1):56-62.

PMID:
11141529
19.

Subjective experience and subjective response to neuroleptics in schizophrenia.

Rossi A, Arduini L, Stratta P, Pallanti S.

Compr Psychiatry. 2000 Nov-Dec;41(6):446-9.

PMID:
11086150
20.

Attitudes towards neuroleptic treatment: reliability and validity of the attitudes towards neuroleptic treatment (ANT) questionnaire.

Kampman O, Lehtinen K, Lassila V, Leinonen E, Poutanen O, Koivisto A.

Schizophr Res. 2000 Oct 27;45(3):223-34.

PMID:
11042440

Supplemental Content

Support Center